Recombinant Human CKS2 Protein，His

CKS2 (Cyclin-Dependent Kinase Subunit 2) is a small, highly conserved protein that plays a critical role in the regulation of cell cycle progression and cellular responses to stress. Its involvement in various cellular processes, including the activation of cyclin-dependent kinases (CDKs), highlights its significance in cell proliferation and division. Recent studies have indicated that CKS2 is not only essential for normal cell cycle functions but also implicated in several pathologies, including cancer, where it is often overexpressed and associated with poor patient prognosis. This has sparked interest in understanding the molecular mechanisms by which CKS2 influences cellular behavior and its potential as a therapeutic target. Researchers are focusing on the structural and functional characterization of CKS2, including its interactions with CDKs and other regulatory proteins, to elucidate its role in cell cycle dysregulation. Recombination techniques are being employed to produce CKS2 fusion proteins for in vitro studies, which enable detailed analysis of its biochemical properties and interactions. Furthermore, investigations into the impact of CKS2 on signal transduction pathways provide insights into its multifaceted roles in maintaining cellular homeostasis. The ongoing research into CKS2 not only enhances our understanding of cell cycle regulation but also opens avenues for developing novel therapeutic strategies aimed at targeting cell proliferation in cancers and other diseases associated with cell cycle abnormalities.